Literature DB >> 6174172

Pruritus after administration of hetastarch.

N E Parker, J B Porter, H J Williams, N Leftley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174172      PMCID: PMC1496008          DOI: 10.1136/bmj.284.6313.385-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch.

Authors:  K B McCredie; E J Freireich; J P Hester; C Vallejos
Journal:  Transfusion       Date:  1974 Jul-Aug       Impact factor: 3.157

2.  Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis.

Authors:  U Bode; A B Deisseroth
Journal:  Transfusion       Date:  1981 Jan-Feb       Impact factor: 3.157

3.  Plasma expansion during granulocyte procurement: cumulative effects of hydroxyethyl starch.

Authors:  G Rock; P Wise
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

4.  New dosage regimens for HES during intensive leukapheresis.

Authors:  J M Mishler
Journal:  Transfusion       Date:  1978 Jan-Feb       Impact factor: 3.157

5.  Intravascular persistence of hydroxyethyl starch in man.

Authors:  J C Boon; F Jesch; J Ring; K Messmer
Journal:  Eur Surg Res       Date:  1976       Impact factor: 1.745

  5 in total
  3 in total

1.  Hydroxyethylstarch deposits in human skin--a model for pruritus?

Authors:  W Jurecka; Z Szépfalusi; E Parth; W Schimetta; W Gebhart; O Scheiner; D Kraft
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

2.  Human monocytes and keratinocytes in culture ingest hydroxyethylstarch.

Authors:  Z Szépfalusi; E Parth; W Jurecka; T A Luger; D Kraft
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

3.  [Hydroxyethyl starch-(HES)-induced pruritus as secondary complication of an occupational accident].

Authors:  E Weisshaar; S Ständer; D Metze; T L Diepgen
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.